We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $289B
1-Year Est. Return 60.46%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+3.07%
1 Year Est. Return
+60.46%
3 Year Est. Return
+148.24%
5 Year Est. Return
+163.86%
10 Year Est. Return
+570.16%
AUM
$129B
AUM Growth
-$8.45B
Cap. Flow
+$31.1B
Cap. Flow %
24.16%
Top 10 Hldgs %
38.15%
Holding
4,322
New
186
Increased
1,218
Reduced
1,541
Closed
956

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.64B
2
EQIX icon
Equinix
EQIX
+$2.21B
3
TSLA icon
Tesla
TSLA
+$2.19B
4
SNDK
SANDISK CORP
SNDK
+$1.51B
5
TRLA
TRULIA INC (DEL)
TRLA
+$1.5B

Sector Composition

Rank Sector Weight
1 Technology 25.86%
2 Healthcare 23.62%
3 Consumer Discretionary 8.66%
4 Financials 5.93%
5 Real Estate 4.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBIO icon
3026
iBio
IBIO
$70.5M
0
OCSL icon
3027
Oaktree Specialty Lending
OCSL
$1.15B
$531 ﹤0.01%
19
-573
-97% -$16.3K
IMGN
3028
DELISTED
Immunogen Inc
IMGN
$531 ﹤0.01%
41
-1,056
-96% -$16.6K
RCKY icon
3029
Rocky Brands
RCKY
$356M
$527 ﹤0.01%
36
REXX
3030
DELISTED
Rex Energy Corporation
REXX
$527 ﹤0.01%
3
-56
-95% -$10.2K
GST
3031
DELISTED
Gastar Exploration Inc.
GST
$524 ﹤0.01%
+79
New +$482
SUMR
3032
DELISTED
Summer Infant, Inc.
SUMR
$523 ﹤0.01%
31
SES
3033
DELISTED
Synthesis Energy Systems Inc.
SES
$519 ﹤0.01%
5
LOCK
3034
DELISTED
LifeLock, Inc.
LOCK
$518 ﹤0.01%
33
-754
-96% -$14.7K
MRCY icon
3035
Mercury Systems
MRCY
$6.6B
$517 ﹤0.01%
37
-381
-91% -$4.33K
COB
3036
DELISTED
CommunityOne Bancorp
COB
$517 ﹤0.01%
53
-93
-64% -$1.07K
DWSN icon
3037
Dawson Geophysical
DWSN
$102M
$516 ﹤0.01%
36
-56
-61% -$1.08K
SUPN icon
3038
Supernus Pharmaceuticals
SUPN
$2.77B
$509 ﹤0.01%
62
-138
-69% -$1.27K
STAB
3039
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$508 ﹤0.01%
41
SIFI
3040
DELISTED
SI Financial Group, Inc. NEW MD
SIFI
$507 ﹤0.01%
43
HBCP icon
3041
Home Bancorp
HBCP
$571M
$506 ﹤0.01%
25
-1
-4% -$21
EIGI
3042
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$506 ﹤0.01%
40
-227
-85% -$3.05K
LCAV
3043
DELISTED
LCA-VISION INC
LCAV
$504 ﹤0.01%
94
ATRS
3044
DELISTED
Antares Pharma, Inc.
ATRS
$503 ﹤0.01%
181
-1,282
-88% -$5.69K
CCUR
3045
DELISTED
CCUR Holdings, Inc. Common Stock
CCUR
$503 ﹤0.01%
60
BGMD
3046
DELISTED
BG MEDICINE INC COM STK NEW
BGMD
$503 ﹤0.01%
103
TZOO icon
3047
Travelzoo
TZOO
$74.7M
$502 ﹤0.01%
28
-4,598
-99% -$105K
ININ
3048
DELISTED
Interactive Intelligence Group, inc.
ININ
$501 ﹤0.01%
8
-308
-97% -$22.7K
CULP icon
3049
Culp Inc
CULP
$43.8M
$487 ﹤0.01%
27
-78
-74% -$1.55K
SEEL
3050
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0

Similar funds

BNP Paribas Financial Markets's Q1 2014 Portfolio in Review

As of Q1 2014, BNP Paribas Financial Markets held 4,322 positions worth $129B, down 6.2% from $137B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

BNP Paribas Financial Markets deployed $31.1B of net new capital in Q1 2014, opening 186 new positions and adding to 1,218 existing holdings. Its largest new stake was JOYY Inc: 14,000,000 shares worth $1.21B.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $277M trimmed.

  • BNP Paribas Financial Markets's largest Q1 2014 buy was JOYY Inc: 14,000,000 shares worth $1.21B.
  • BNP Paribas Financial Markets added most to Gilead Sciences in Q1 2014, an estimated $3.64B increase.
  • BNP Paribas Financial Markets's biggest Q1 2014 reduction was Alphabet (Google) Class C, cutting an estimated $277M.
  • BNP Paribas Financial Markets fully exited Jakks Pacific in Q1 2014, selling an estimated $231M.
  • BNP Paribas Financial Markets's ten largest holdings make up 38% of its $129B portfolio in Q1 2014.
  • BNP Paribas Financial Markets opened 186 new positions and closed 956 in Q1 2014.
  • BNP Paribas Financial Markets's portfolio value fell 6.2% quarter-over-quarter to $129B.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2014, filed 13 May 2014.